BETHLEHEM, Pa., Oct. 11, 2017 -- B. Braun Medical Inc. will present its chronic care products at the Symposium on Advanced Wound Care Fall 2017 (SAWC) in Las Vegas, Nevada, from October 20 to 22. Attendees can visit booth #208 to learn about the Prontosan® line of wound healing products and the Flexima® 3S line of ostomy products, including:
- Prontosan Gel-X, the wound gel with betaine and polyhexanide to resist microbial colonization within a dressing and offer a gentle healing experience1
- Flexima 3S 2-Piece System ostomy product, with a guiding system designed for security
- Roll’Up Drainable Ostomy Pouches, with an integrated soft roll-up outlet
- B. Braun High Output System, including the High Output Pouch and Flow Collector with a 2-liter collection bag and kink-resistant, cuttable 5-foot-long white tubing
- Urostomy Pouches, featuring an open/closed tap with tactile open/close tap outlet
“With B. Braun Melsungen’s more than 40 years of experience with ostomy products and an extensive line of wound care products, B. Braun Medical will continue to extend its unique product solutions to patients and clinicians in the North American market,” said Jeff Straton, Vice President of New Business Development for B. Braun.
At SAWC, B. Braun will preview its myostoSM program for those living with an ostomy. For patients pre-surgery to many years post-ostomy, the soon-to-be-launched myosto program will include an online website resource and toll-free contact numbers that will offer general information about living with a stoma and measure patient satisfaction with B. Braun ostomy products.
For more information, visit www.BBraunUSA.com.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 58,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
1 Bradbury s., Fletcher J. Prontosan Made Easy. Wounds Int. 2011.2(2), 1-6.
Contact:
Jason Ford
B. Braun Medical Inc.
610.997.4722
[email protected]


Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Jefferies Upgrades Starbucks to Hold as China JV Deal Closes and U.S. Business Shows Signs of Recovery
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
AI Deradicalization Tools: How Chatbots Could Help Combat Violent Extremism Online
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home 



